Notice of Intent to sole source - Chemistry Cost-Per-Test; Military Treatment Facilities at Corpus Christi and Fort Worth, Texas

The Defense Health Agency (DHA) is issuing a sole‑source, cost‑per‑test (CPT) contract for two low‑volume, floor‑model clinical chemistry analyzers (VITROS XT 3400) and all associated reagents, consumables, maintenance, and lease services for two Military Treatment Facilities (MTFs) – NMRTC Corpus Christi and NMRTU Fort Worth, Texas. The contractor must be an authorized OEM dealer, provide installation, validation, ATO documentation, bi‑directional HL7 interface with MHS Genesis, on‑site corrective maintenance, preventive maintenance, training, and supply deliveries every six months. The contract runs a base year (01 Oct 2026 – 30 Sep 2027) with four optional one‑year extensions, for a total possible performance period of five years. • Sole‑source award to QUIDELORTHO SALES COMPANY, LLC (NAICS 334516) • Two chemistry analyzers (VITROS XT 3400) with full CPT pricing model • Annual test volume ≈ 76,130 assays across both sites • Required ATO package and HL7 (MHS Genesis) bi‑directional connectivity • Maintenance window: M‑F 07:30‑16:30, unlimited service calls, 24‑hr on‑site response • Training: on‑site + two vendor‑site sessions per location, travel & lodging covered • Delivery of reagents/consumables every six months; no external water or drainage needed • Contract period: 1 base year + up to 4 option years (5 years total)